Barriers to hydroxyurea use from the perspectives of providers, individuals with sickle cell disease, and families: Report from a U.S. regional collaborative.

Front Genet · 2022 · PMC9461276 · PMID 36092883

Europe PMC DOI

hedged sentence

0.0120

closest p · 0.2× alpha

0.0120

boldest claim

The sentences

approached significancep = 0.012actually significant

The presence of one or more barriers approached significance as negatively associated with complete adherence ( p = 0.012).

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.